Navigation Links
Johnson & Johnson Announces Completion of Cordis Divestiture to Cardinal Health
Date:10/4/2015

NEW BRUNSWICK, N.J., Oct. 4, 2015 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced the completion of the divestiture of its Cordis business to Cardinal Health for an approximate value of $2 billion, subject to customary adjustments.

The Cordis business is a global leader in the development and manufacture of interventional vascular technology and generated net revenues of approximately $780 million in 2014.

Johnson & Johnson remains dedicated to combating cardiovascular disease through its electrophysiology business, Biosense Webster, in the Medical Devices segment, and its leading cardiovascular medicine, XARELTO®, in the Pharmaceutical segment.

About Cordis

Cordis is a leader in the development and manufacture of interventional vascular technology, partnering with experts worldwide to treat millions of patients who suffer from vascular disease. The business has operations in more than 50 countries, with an extensive research and development network and a global commercial footprint.

About Johnson & Johnson

Caring for the world, one person at a time, inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 127,000 employees at more than 265 Johnson & Johnson operating companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.


'/>"/>
SOURCE Johnson & Johnson
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. UbiVac Announces Collaboration with Johnson & Johnson Innovation to Develop and Test, in Preclinical Studies, a Vaccine to Intercept Oral Cancer
2. Johnson & Johnsons Ethicon Wants Transvaginal Mesh $1.2MM Verdict Thrown Out, says Legal-Bay Lawsuit Settlement Funding
3. Johnson & Johnson Innovation Announces Collaboration on Immuno-Oncology Antibody ADC-1013 with Alligator Bioscience
4. Global Endoscopy Devices Market 2015-2019 - Key Players are Boston Scientific, Johnson and Johnson, Medtronic, Karl Storz & Olympus
5. Arcturus Therapeutics Announces Strategic Collaboration with Johnson & Johnson Innovation to Discover and Develop RNA Medicines for Defined Indications
6. PDA Announces Support for the Johnson & Johnson Kilmer Conference
7. Johnson & Johnson Pharmaceutical Segment to Continue Driving Above-Industry Growth with Plans to File More than 10 New Products by 2019, Each with Potential to Exceed $1 Billion in Revenue
8. Johnson & Johnson Announces NYU School of Medicine Partnership To Evaluate Compassionate Use of Investigational Medicines
9. PDA Extends Richard M. Johnson as President/CEO for Six Additional Years
10. Johnson & Johnson to Participate in the 2015 Deutsche Bank 40th Annual Health Care Conference
11. Endoscopy Global Market - Forecast to 2020: Market is expected to reach approximately $43 billion with Johnson and Johnson, Olympus and Covidien Dominating
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2020)... ... February 20, 2020 , ... ... program modernization, has been selected to perform Independent Verification and Validation (IV&V) ... Health Insurance Exchange and Integrated Eligibility System (HIX/IES) project. , EOHHS, along ...
(Date:2/19/2020)... ... February 19, 2020 , ... Drs. Mario Canal and Ben ... 20, 2020 at The Mansion in Voorhees. The course features guest speaker, Dr. Amanda ... implants. Dental implants, including All-on-4® full mouth dental implants, are a ...
(Date:2/19/2020)... ... February 19, 2020 , ... ... among the best colleges and universities for people with disabilities. , The ... help people with disabilities succeed in higher education. AIC placed in the top ...
Breaking Medicine Technology:
(Date:2/19/2020)... , ... February 19, 2020 , ... ... film industry. While he is most known for his acting abilities demonstrated in ... on the educational show “Behind The Scenes” with Laurence Fishburne. “Behind The Scenes” ...
(Date:2/19/2020)... Fla. (PRWEB) , ... February 19, 2020 , ... SEAL ... year as a result of healthcare-acquired infections (HAIs.) According to The Centers for Disease ... for is the large amount of screens that are now acting as an extension ...
(Date:2/15/2020)... ... 2020 , ... Sister companies, Special Learning Inc. and ABA Business Growth, are ... series explores the challenges, risks, and opportunities of private equity investment and acquisition in ... at: https://bit.ly/2OU6lxg , Since 2010, more than 60 private equity firms ...
(Date:2/14/2020)... (PRWEB) , ... February 14, 2020 , ... ... were most bothered by excess weight, skin texture and discoloration, and lines and ... tightening and injectables. MilfordMD is offering some great specials in February specifically to ...
(Date:2/13/2020)... , ... February 13, 2020 , ... A January 24 ... that people will be discussing in 2020. It also reports on a well-documented dramatic ... procedures. Dr. Jazayeri says that his patients are increasingly knowledgeable and are asking about ...
Breaking Medicine News(10 mins):